Abstract:Background Remote limb ischemic postconditioning (RLIPoC) has been demonstrated to protect against ischemic stroke. However, the underlying mechanisms of RLIPoC mediating cross‐organ protection remain to be fully elucidated. Methods and Results Ischemic stroke was induced by middle cerebral artery occlusion for 60 minutes. RLIPoC was performed with 3 cycles of 10‐minute ischemia followed by 10‐minute reperfusion of the bilateral femoral arteries immediately after middle cerebral artery reperfusion. The percentage of regulatory T cells (Tregs) in the spleen, blood, and brain was detected using flow cytometry, and the number of Tregs in the ischemic hemisphere was counted using transgenic mice with an enhanced green fluorescent protein‐tagged Foxp3. Furthermore, the metabolic status was monitored dynamically using a multispectral optical imaging system. The Tregs were conditionally depleted in the depletion of Treg transgenic mice after the injection of the diphtheria toxin. The inflammatory response and neuronal apoptosis were investigated using immunofluorescent staining. Infarct volume and neurological deficits were evaluated using magnetic resonance imaging and the modified neurological severity score, respectively. The results showed that RLIPoC substantially reduced infarct volume, improved neurological function, and significantly increased Tregs in the spleen, blood, and ischemic hemisphere after middle cerebral artery occlusion. RLIPoC was followed by subsequent alteration in metabolites, such as flavin adenine dinucleotide and nicotinamide adenine dinucleotide hydrate, both in RLIPoC‐conducted local tissues and circulating blood. Furthermore, nicotinamide adenine dinucleotide hydrate can mimic RLIPoC in increasing Tregs. Conversely, the depletion of Tregs using depletion of Treg mice compromised the neuroprotective effects conferred by RLIPoC. Conclusions RLIPoC protects against ischemic brain injury, at least in part by activating and maintaining the Tregs through the nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide hydrate pathway. Nonstandard Abbreviations and Acronyms DEREG depletion of regulatory T cell DT diphtheria toxin FAD flavin adenine dinucleotide MCAO middle cerebral artery occlusion NAD + nicotinamide adenine dinucleotide NADH nicotinamide adenine dinucleotide hydrate RLIPoC remote limb ischemic postconditioning Tregs regulatory T cells Clinical Perspective What Is New? Remote limb ischemic postconditioning attenuating ischemic brain injury is partly responsible for an increase in regulatory T cells. Remote limb ischemic postconditioning promotes thriving of regulatory T cells by modifying the spectrum of metabolites, especially the decrease of nicotinamide adenine dinucleotide:nicotinamide adenine dinucleotide hydrate ratio. What Are the Clinical Implications? Easily feasible in patients, remote limb ischemic postconditioning has high potential for acute ischemic stroke therapy. Modification of nicotinamide adenine dinucleotide:nicotinamide adenine dinucleotide hydrate ratio may have translational implications because of its effects on the abundance of regulatory T cells. Ischemic stroke is a growing threat to human health, given its high mortality and morbidity. 1 , 2 Unfortunately, only a few treatments for acute cerebral infarction have been approved; they include intravenous thrombolysis and vascular recirculation mechanical thrombectomy, which have a narrow time window and limited applicable population. 3 , 4 , 5 Therefore, tremendous efforts have been made to develop more potential therapies. Research on ischemic postconditioning, a therapeutic procedure with several episodes of sublethal ischemia or reperfusion in primary or distant organs to protect primary organs against ischemic damage, has be -Abstract Truncated-

Adoptive Regulatory T-Cell Therapy Preserves Systemic Immune Homeostasis After Cerebral Ischemia

Abstract W P89: Adoptive Regulatory T Cell Therapy Preserves Systemic Immune Homeostasis Following Cerebral Ischemia

Adoptive Regulatory T-cell Therapy Protects Against Cerebral Ischemia.

Abstract 3856: Adoptive Transfer of Regulatory T Cells Confers Long Term Neuroprotection Against Cerebral Ischemic Stroke

Abstract WP168: Regulatory T Cell Transplantation Inhibits Cerebral Endothelial Inflammation in Mice Transient Focal Ischemia.

Regulatory T Cell is Critical for Interleukin-33-mediated Neuroprotection Against Stroke.

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Essential Role of Program Death 1-Ligand 1 in Regulatory T-cell-afforded Protection Against Blood-Brain Barrier Damage after Stroke.

Abstract T MP18: in Vivo Expansion of Regulatory T Cells with Interleukin-2/Interleukin-2-antibody Complex Protects Against Transient Ischemic Stroke

Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke

Indispensable Role Of Ccr5 Signaling In Tregs Protection Against Early Blood Brain Barrier Disruption After Stroke

Depletion of regulatory T cells exacerbates inflammatory responses after chronic cerebral hypoperfusion in mice

Regulatory T Cells Ameliorate Tissue Plasminogen Activator-Induced Brain Haemorrhage after Stroke

Regulatory T cell expansion promotes white matter repair after stroke

C-C Chemokine Receptor Type 5 (CCR5)-Mediated Docking of Transferred Tregs Protects Against Early Blood-Brain Barrier Disruption After Stroke.

TCRαβ + NK1.1 - CD4 - CD8 - double-negative T cells inhibit central and peripheral inflammation and ameliorate ischemic stroke in mice

T Cells Modulate the Microglial Response to Brain Ischemia

Activated Regulatory T Cell Regulates Neural Stem Cell Proliferation in the Subventricular Zone of Normal and Ischemic Mouse Brain Through Interleukin 10

Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery

Remote Limb Ischemic Postconditioning Protects Against Ischemic Stroke by Promoting Regulatory T Cells Thriving.

Regulatory T Cells Secrete IL10 to Suppress Neuroinflammation in Early Stage after Subarachnoid Hemorrhage